Das Medizinportal

Das Medizinportal

Passwort vergessen?

Bitte geben Sie Ihren Ihre E-Mail-Adresse ein. Anweisungen zum Zurücksetzen des Passworts werden Ihnen umgehend per E-Mail übermittelt.


Patientenverständnis als Schlüssel zur erfolgreichen Behandlung (Seite 14-18)
Christian Karl Brinkmann

  1. Sabaté, E., WHO Adherence to Long Term Therapies: evidence for action , WHO Dept. of Management of Noncommunicable Diseases. (2003)
  2. 4. EGS Guidelines 2014
  3. Khouri AS et al. Drugs Aging 2007;24(12):1007-16
  4. Zimmerman TJ, et al. J Ocul Pharmacol Ther  2009
  5. R. Susanna, MD, Ophthalmology Times Europe, Oct 2010
  6. Kass MA, Hodapp E, Gordon M, & al. Patient administration of eye drops: interview part 1. Ann Ophthalmol. 1982;14:775–779
  7. Erb et al, Klin Monatsbl Augenheilkd 2014; 231: 136–143
  8. N. Baig, Medical Bulletin Vol.15 No.10 October 2010
  9. Wan MJ, J of Glaucoma 2010 (Dec)
  10. Leitritz & al., Originalpräparat versus Generika – Latanoprost Ophthalmologe 2015
  11. Wegner A , Klein Monatsbl Augenheilkd 2011;228, R45-56
  12. Franz Grehn & Thomas Klink, Nachsorge nach Glaukomoperationen Z. prakt. Augenheilkd. 30: 235-243 (2009)
  13. Thomas W. Samuelson, Keeping Your Trabeculectomy On Track, Review of Ophthalmology, 10.01.2017

Management des primären kongenitalen Glaukoms (Seite 20-27 )
Anselm G. M. Jünemann

  1. Beck A, Chang TCP, Freedman S. Definition, classification and differential diagnosis. In: Weinreb RN, Grajewski A, Papadopoulos M, Grigg J, Freedman S (Eds.), Childhood Glaucoma. In: WGA Consensus Series, vol. 9. Kugler Publications, Amsterdam, 2013; 3–10
  2. Papadopoulos M, Cable N, Rahi J, Khaw PT, BIG Eye Study Investigators. The British infantile and childhood glaucoma (BIG) eye study. Invest Ophthalmol Vis Sci 2007; 48: 4100–4106
  3. Elder MJ. Congenital glaucoma in the West Bank and Gaza Strip. Br J Ophthalmol 1993; 77: 413–416
  4. Sarfarazi, M., Stoilov, I., 2000. Molecular genetics of primary congenital glaucoma. Eye 14, 422–428.
  5. Goebels S, Eppig T, Wagenpfeil S, Cayless A, Seitz B, Langenbucher A: Complementary keratoconus indices based on topographical interpretation of biomechanical wave form parameters – a supplement to established keratoconus indices. Comput Math Methods Med 2017; 2017:5293573 
  6. Stachon T, Kolev K, Flaskó Z, Seitz B, Langenbucher A, Szentmáry N: Arginase activity, urea concentration and hydroxyproline secretion are reduced in keratoconus keratocytes. Graefes Arch Clin Exp Ophthalmol 2017; 255:91-97
  7. Suri F, Yazdani S, Narooie-Nejhad M, Zargar S et al. Variable expressivity and high penetrance of CYP1B1 mutations associated with primary congenital glaucoma. Ophthalmology 2009; 116: 2101–2109
  8. Abu-Amero K, Osman E, Mousa A, Wheeler J, et al. Screening of CYP1B1 and LTBP2 genes in Saudi families with primary congenital glaucoma: genotype-phenotype correlation. Mol Vis 2011; 17: 2911–2919
  9. Ramırez JM, Ramırez AI, Salazar JJ, Rojas B, De Hoz R, Trivino A. Schlemm’s canal and the collector channels at different developmental stages in the human eye. Cells Tissues Organs 2004; 178: 180–185
  10. Abdolrahimzadeh S, Fameli V, Mollo R, Contestabile MT, Perdicchi A, Recupero SM. Rare Diseases Leading to Childhood Glaucoma: Epidemiology, Pathophysiogenesis, and Management. Biomed Res Int 2015;2015:781294. doi: 10.1155/2015/781294
  11. Zagora SL, Funnell CL, Martin FJ, Smith JE, Hing S, Billson FA, Veillard AS, Jamieson RV, Grigg JR. Primary congenital glaucoma outcomes: lessons from 23 years of follow-up. Am J Ophthalmol 2015; 159:788–796
  12. DiMaggio C, Sun LS, Li G. Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort. Anesth Analg 2011; 113: 1143–1151
  13. Arribas-Pardo P, Mendez-Hernández C, Valls-Ferran I, Puertas-Bordallo D. Icare-Pro Rebound Tonometer Versus Hand-held Applanation Tonometer for Pediatric Screening. J Pediatr Ophthalmol Strabismus 2018; 27:1-5 doi: 10.3928/01913913-20180621-01 [Epub ahead of print]
  14. Mikhail M, Sabri K, Levin AV. Effect of anesthesia on intraocular pressure measurement in children. Surv Ophthalmol 2017; 62:648-658 doi: 10.1016/j.survophthal.2017.04.003. Epub 2017 Apr 22. Review.
  15. Dietlein TS, Jacobi PC, Krieglstein GK. Prognosis of primary ab externo surgery for primary congenital glaucoma. Arch Ophthalmol 2000; 118: 1037–1043
  16. Girkin CA, Rhodes L, McGwin G, et al. Goniotomy versus circumferential trabeculotomy with an illuminated microcatheter in congenital glaucoma. J. AAPOS 2012; 16: 424–427
  17. Grover DS, Smith O, Fellman RL, et al. Gonioscopy assisted transluminal trabeculotomy: an ab interno circumferential trabeculotomy for the treatment of primary congenital glaucoma and juvenile open angle glaucoma. Br J Ophthalmol 2015; 99: 1092–1096
  18. Ko F, Papadopoulos M, Khaw PT. Primary congenital glaucoma. Prog Brain Res. 2015; 221:177-89. doi: 10.1016/bs.pbr.2015.06.005.
  19. Gressel MG, Heuer DK, Parrish RK. Trabeculectomy in young patients. Ophthalmology 1984; 91:1242–1246
  20. Chen TC, Chen PP, Francis BA, et al. Pediatric glaucoma surgery: a report by the american academy of ophthalmology. Ophthalmology 2014; 121: 2107–2115

Kontinuierliche Augendruckmessung – wie (un)realistisch ist sie?“  (Seite 28-31)
Christoph Faschinger

  1. De Crom RMPC, Webers CAB, van Kooten-Noordzij MAW, et al. Intraocular pressure fluctuations and 24-hour continuous monitoring for glaucoma risk in wind instrument players. J Glaucoma 2017; 26: 923-928
  2. Grippo TM, Liu JHK, Zebardast N, et al. Twenty-four-hour pattern of intraocular pressure in untreated patients with ocular hypertension. Invest Ophthalmol Vis Sci 2013; 54: 512-517
  3. Liu JHK, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in aging population. Invest Ophthalmol Vis Sci 1999; 40: 2912-2917
  4. Realini T, Weinreb RN, Wisniewski SR. Short-time repeatability of diurnal intraocular pressure patterns in glaucomatous individuals. Ophthalmology 2011; 118: 47-51
  5. Caprioli J, Coleman AL. Intraocular pressure fluctuation. A risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 2008; 115: 1123-1129
  6. Kooner KS, AlBdoor M, Cho BJ, et al. Risk factors for progression to blindness in high tension primary open angle glaucoma: Comparison of blind and nonblind subjects. Clin Ophthalmol 2008; 2: 757-762
  7. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007; 114: 205-209
  8. Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversation from ocular hypertension to glaucoma. Ophthalmology 2008; 115: 934-940
  9. Quaranta L, Riva I, Oddone F. 24-hour IOP fluctuations: myth or reality? J Model Ophthalmol 2016; 2: 103-109
  10. Huang J, Katalinic P, Kalloniatis M, et al. Diurnal intraocular pressure fluctuations with self-tonometry in glaucoma patients and suspects: A clinical trial. Optom Vis Sci 2018; 95: 88-95
  11. Fischer N, Weinand F, Kügler MU, et al. Sinnhaftigkeit von Tages-/Nacht-Augeninnendruckmessungen über 48 h. Ophthalmologe 2013; 110: 755-760
  12. Cook JA, Botello AP, Elders A, et al. Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 2012; 119: 1522-1577
  13. Leonardi M, Pitchon EM, Bertsch A, et al. Wireless contact lens sensor for intraocular pressure monitoring: assessment on enucleated pig eyes. Acta Ophthalmol 2009; 87: 433-437
  14. Hedinger A, Kniestedt C, Zweifel S. et al. Kontinuierliche Augeninnendruckmessung. Ophthalmologe 2009; 106: 1111-1115
  15. Mariacher S, Ebner M, Hurst J, et al. Implantation and testing of a novel episcleral pressure transducer: A new approach to telemetric intraocular pressure monitoring. Exp Eye Res 2018; 166: 84-90
  16. Koutsonas A, Walter P, Roessler G, et al. Implantation of a novel telematics intraocular pressure sensor in patients with glaucoma (ARGOS study): 1-year results. Invest Ophthalmol Vis Sci 2015; 56: 1063-1069
  17. Ittoop SM, SooHoo JR, Seibold LK, et al. Systematic review of current devices for 24-h intraocular pressure monitoring. Adv Ther 2016; 33: 1679-1690
  18. Gautam N, Kaur S, Kaushik S, et al. Postural and diurnal fluctuations in intraocular pressure across the spectrum of glaucoma.Br J Ophthalmol 2016; 100: 537-541

Glaukom und altersbedingte Makuladegeneration: Eine unklare Beziehung
(Seite 32-34)

Erdem Ergun

  1. Varin VM, Kergoat MJ, Belville S et al. Age-Related Eye Disease and Participation in Cognitive Activities Sci Rep. 2017 Dec 21;7(1):17980. doi: 10.1038/s41598-017-18419-2
  2. Bracha P, Moore NA, Ciulla TA et al. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review. Surv Ophthalmol. 2018 May - Jun;63(3):281-295. doi: 10.1016/j.survophthal.2017.08.008.
  3. Frenkel MP, Haji SA, Frenkel RE. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections. Arch Ophthalmol. 2010 Dec;128(12):1523-7. doi: 10.1001/archophthalmol.2010.297.
  4. Lemos V, Cabugueira A, Noronha M et al. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections. Ophthalmologica. 2015;233(3-4):162-8. doi: 10.1159/000369478.
  5. Griffith JF, Goldberg AL Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center Clin Ophthalmol. 2015 Jul 13;9:1275-84. doi: 10.2147/OPTH.S85851.
  6. Hu CC, Ho JD, Lin HC et al. Association between open-angle glaucoma and neovascular age-related macular degeneration: a case-control study. Eye (Lond). 2017 Jun;31(6):872-877. doi: 10.1038/eye.2016.325.
  7. Zlateva GP, Javitt JC, Shah SN et al. Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population. Retina. 2007 Nov-Dec;27(9):1292-9.
  8. Cuellar-Partida G, Craig JE, Burdon KP et al. Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degeneration. Sci Rep. 2016 May 31;6:26885. doi: 10.1038/srep26885.
  9. Bachmann BO, Laaser K, Cursiefen C, Kruse FE (2010) A method to confirm correct orientation of descemet membrane during descemet membrane endothelial keratoplasty. Am J Ophthalmol 149 (6):922-925 e922. doi:10.1016/j.ajo.2010.01.005
  10. Foss AJ, Scott LJ, Rogers CA et al. Changes in Intraocular Pressure in study and fellow eyes in the IVAN trial. Br J Ophthalmol. 2016 Dec;100(12):1662-1667. doi: 10.1136/bjophthalmol-2015-307595
  11. Liu L, Ammar DA, Ross LA et al. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):1023-34. doi: 10.1167/iovs.10-6431.
  12. Ricca AM, Morshedi RG, Wirostko BM. High intraocular pressure following anti-vascular endothelial growth factor therapy: proposed pathophysiology due to altered nitric oxide metabolism. J Ocul Pharmacol Ther. 2015 Feb;31(1):2-10. doi: 10.1089/jop.2014.0062.
  13. Lanzl I, Kotliar K. Can Anti-VEGF Injections Cause Glaucoma or Ocular Hypertension? Klin Monbl Augenheilkd. 2017 Feb;234(2):191-193. doi: 10.1055/s-0043-101819.
  14. Morshedi RG, Ricca AM, Wirostko BM. Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide. J Glaucoma. 2016 Mar;25(3):291-300. doi: 10.1097/IJG.0000000000000173.
  15. Wen JC, Reina-Torres E, Sherwood JM. Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1893-1898. doi: 10.1167/iovs.16-20786.
  16. Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F, et al. Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab. Invest Ophthalmol Vis Sci. 2012; 53: 6214–6218.
  17. Shin HJ, Kim SN, Chung H et al. Intravitreal Anti-Vascular Endothelial Growth Factor Therapy and Retinal Nerve Fiber Layer Loss in Eyes With Age-Related Macular Degeneration: A Meta-Analysis. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1798-806. doi: 10.1167/iovs.15-18404.
  18. Saleh R, Karpe A, Zinkernagel MS et al. Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):817-824. doi: 10.1007/s00417-017-3590-4.
    Erste Erfahrungen mit dem neuen suprachoroidalen Drainage-Implantat in der Glaukomchirurgie (Seite 35-37)
    Susanna König, Christoph W. Hirneiß
  1. Bill A, Phillips CI. Uveoscleral drainage of aqueous humour in human eyes. Experimental eye research. 1971 Nov;12(3):275-81.
  2. Mosaed S, Minckler DS. Aqueous shunts in the treatment of glaucoma. Expert review of medical devices. 2010 Sep;7(5):661-6.
  3. Pourjavan S., Collignon N.J.M., De Groot V., Eiferman R.A., Marshall A.J., Roy C.J. STARfloTM: A Suprachoroidal Drainage Implant Made from STAR Biomaterial. 2014. In: Surgical Innovations in Glaucoma [Internet]. New York: Springer; [235 - 51].
  4. Hueber A, Roters S, Jordan JF, Konen W. Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC ophthalmology. 2013 Jul 18;13:35.
  5. Vold S, Ahmed, II, Craven ER, Mattox C, Stamper R, Packer M, et al. Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts. Ophthalmology. 2016 Oct;123(10):2103-12.